The Net Margin of CStone Pharmaceuticals (2616.HK) is -22.40%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -22.40% |
| 2023-12-31 | -79.17% |
| 2022-12-31 | -187.53% |
| 2021-12-31 | -787.84% |
| 2020-12-31 | -117.54% |
| 2019-12-31 | -117.54% |